Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of beta2-adrenergic receptor polymorphism in asthma control of patients receiving combination treatment.

Yonsei medical journal - 30 Apr 2009

Kim Seung-Hyun, Ye Young-Min, Hur Gyu-Young, Lee Hyun-Young, Jee Young-Koo, Lee Seung-Ho, Holloway John W, Park Hae-Sim

Abstract excerpt

PURPOSE: Combination treatment of inhaled corticosteroid (ICS) plus long-acting beta2-agonist (LABA) is widely used as a maintenance regimen for the management of asthma. This study evaluated the effect of the beta2-adrenergic receptor (ADRB2) polymorphism on lung function and asthma control with regular use of combination treatment of an inhaled ICS plus LABA. MATERIALS AND METHODS: 43 Korean asthmatics who were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Inhalation
Share to Adrenal Cortex Hormones

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Adrenergic beta-Agonists

Share to Asthma

Share to FEV gene

Share to Genotype

Share to Receptors, Adrenergic, beta-2

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 19430548
DOI: 10.3349/ymj.2009.50.2.182
PMCID: PMC2678690

Genes

ADRB2
FEV

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of beta2-adrenergic receptor polymorphism in asthma control of patients receiving combination treatment.PMID 19430548Read ↗

Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies.Semantic proximity Read ↗

Beta-2 adrenergic receptor (ADRB2) gene polymorphisms and the risk of asthma: a meta-analysis of case-control studies.Semantic proximity Read ↗

Beta2-adrenoceptor polymorphisms and obstructive airway diseases: important issues of study design.Semantic proximity Read ↗

Combined pharmacogenetic effect of ADCY9 and ADRB2 gene polymorphisms on the bronchodilator response to inhaled combination therapySemantic proximity Read ↗

Variants of the ADRB2 Gene in COPD: Systematic Review and Meta-Analyses of Disease Risk and Treatment Response.Semantic proximity Read ↗

The significance of beta2-adrenergic receptor polymorphisms in asthma.Semantic proximity Read ↗

Asthma: Gln27Glu and Arg16Gly polymorphisms of the beta2-adrenergic receptor gene as risk factorsSemantic proximity Read ↗

Pharmacogenomics of long-acting β2-agonists.Semantic proximity Read ↗

Effect of ADRB2 (adrenergic receptor β2) gene polymorphisms on the occurrence of asthma and on the response to nebulized salbutamol in South Indian patients with bronchial asthma.Semantic proximity Read ↗

The effects of a Gly16Arg ADRB2 polymorphism on responses to salmeterol or montelukast in Japanese patients with mild persistent asthma.Semantic proximity Read ↗

Lung function response to 12-week treatment with combined inhalation of long-acting beta2 agonist and glucocorticoid according to ADRB2 polymorphism in patients with chronic obstructive pulmonary disease.Semantic proximity Read ↗

Possible protective effects of the Glu27 allele of beta2-adrenergic receptor polymorphism in Thai asthmatic patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.